These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
395 related articles for article (PubMed ID: 19026757)
21. Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths. Salpeter SR; Buckley NS; Ormiston TM; Salpeter EE Ann Intern Med; 2006 Jun; 144(12):904-12. PubMed ID: 16754916 [TBL] [Abstract][Full Text] [Related]
22. Inhaled steroids with and without regular salmeterol for asthma: serious adverse events. Cates CJ; Schmidt S; Ferrer M; Sayer B; Waterson S Cochrane Database Syst Rev; 2018 Dec; 12(12):CD006922. PubMed ID: 30521673 [TBL] [Abstract][Full Text] [Related]
23. Stopping long-acting beta2-agonists (LABA) for children with asthma well controlled on LABA and inhaled corticosteroids. Kew KM; Beggs S; Ahmad S Cochrane Database Syst Rev; 2015 May; 2015(5):CD011316. PubMed ID: 25997166 [TBL] [Abstract][Full Text] [Related]
24. Long-acting β-agonists in asthma management: what is the current status? Mysore S; Ruffin RE Drugs; 2011 Nov; 71(16):2091-7. PubMed ID: 22035511 [TBL] [Abstract][Full Text] [Related]
25. Long-acting beta-agonists: a review of formoterol safety data from asthma clinical trials. Sears MR; Ottosson A; Radner F; Suissa S Eur Respir J; 2009 Jan; 33(1):21-32. PubMed ID: 18768573 [TBL] [Abstract][Full Text] [Related]
26. Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids. Chan J; Hui RL; Spence MM J Manag Care Pharm; 2007; 13(1):21-7. PubMed ID: 17269833 [TBL] [Abstract][Full Text] [Related]
27. Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized Clinical Trial. Wechsler ME; Yawn BP; Fuhlbrigge AL; Pace WD; Pencina MJ; Doros G; Kazani S; Raby BA; Lanzillotti J; Madison S; Israel E; JAMA; 2015 Oct; 314(16):1720-30. PubMed ID: 26505596 [TBL] [Abstract][Full Text] [Related]
28. Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events. Cates CJ; Lasserson TJ Cochrane Database Syst Rev; 2009 Oct; (4):CD007695. PubMed ID: 19821436 [TBL] [Abstract][Full Text] [Related]
29. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study. Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690 [TBL] [Abstract][Full Text] [Related]
30. Safe use of long-acting β-agonists: what have we learnt? Sears MR Expert Opin Drug Saf; 2011 Sep; 10(5):767-78. PubMed ID: 21521133 [TBL] [Abstract][Full Text] [Related]
31. Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review. Joos S; Miksch A; Szecsenyi J; Wieseler B; Grouven U; Kaiser T; Schneider A Thorax; 2008 May; 63(5):453-62. PubMed ID: 18443162 [TBL] [Abstract][Full Text] [Related]
32. Safety of formoterol in adults and children with asthma: a meta-analysis. Kemp J; Armstrong L; Wan Y; Alagappan VK; Ohlssen D; Pascoe S Ann Allergy Asthma Immunol; 2011 Jul; 107(1):71-8. PubMed ID: 21704888 [TBL] [Abstract][Full Text] [Related]
34. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Nelson HS; Weiss ST; Bleecker ER; Yancey SW; Dorinsky PM; Chest; 2006 Jan; 129(1):15-26. PubMed ID: 16424409 [TBL] [Abstract][Full Text] [Related]
35. The safety of long-acting beta-agonists among patients with asthma using inhaled corticosteroids: systematic review and metaanalysis. Jaeschke R; O'Byrne PM; Mejza F; Nair P; Lesniak W; Brozek J; Thabane L; Cheng J; Schünemann HJ; Sears MR; Guyatt G Am J Respir Crit Care Med; 2008 Nov; 178(10):1009-16. PubMed ID: 18776152 [TBL] [Abstract][Full Text] [Related]
36. Dispensation of long-acting β agonists with or without inhaled corticosteroids, and risk of asthma-related hospitalisation: a population-based study. Sadatsafavi M; Lynd LD; Marra CA; FitzGerald JM Thorax; 2014 Apr; 69(4):328-34. PubMed ID: 24281327 [TBL] [Abstract][Full Text] [Related]
37. Safety of long-acting beta-agonists: are new data really required? Sears MR Chest; 2009 Aug; 136(2):604-607. PubMed ID: 19505986 [TBL] [Abstract][Full Text] [Related]
38. A systematic review of long-acting β2-agonists versus higher doses of inhaled corticosteroids in asthma. Castro-Rodriguez JA; Rodrigo GJ Pediatrics; 2012 Sep; 130(3):e650-7. PubMed ID: 22926172 [TBL] [Abstract][Full Text] [Related]
39. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Sobieraj DM; White CM; Coleman CI Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985 [TBL] [Abstract][Full Text] [Related]